7.95MMarket Cap0.00P/E (TTM)
1.280High1.140Low186.38KVolume1.140Open1.180Pre Close223.61KTurnover2.97%Turnover Ratio0.00P/E (Static)6.62MShares128.00052wk High1.73P/B7.53MFloat Cap0.42052wk Low--Dividend TTM6.28MShs Float5600.000Historical High--Div YieldTTM11.86%Amplitude0.420Historical Low1.199Avg Price1Lot Size
Transcode Therapeutics Stock Forum
TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
TransCode Therapeutics (NASDAQ: RNAZ) announced positive preliminary data from its Phase 0 clinical trial for TTX-MC138, their lead RNA-based therapeutic candidate. The trial showed significant inhibition of the molecular target miRNA-10b, with a 66% reduction in the patient's blood 24 hours post-administration. This inhibition is...
$Borealis Foods Inc. (BRLS)$: +98.75%.
$Snap Inc. (SNAP)$: Notable increase following positive news and potential regulatory changes.
$Mullen Automotive Inc. (MULN)$: Volatile with low float, ideal for day traders.
$TransCode Therapeutics, Inc. (RNAZ)$: +55.65% due to advances in biotechnology.
$Akso Health Group (AHG)$: +67.14%, with growth in the health sector.
$Accelerate Diagnostics, Inc. (AXDX)$: +56.46%, momentum in medical diagnostics.
$Bakkt Holdings, Inc. (B...
No comment yet